Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Innoviva Inc (INVA)

  • Event
  • July 20, 2022, 13:20 UTC
  • 14
  • 1 comments

(99% Neutral) INNOVIVA, INC. (INVA) Announces Business Combination

Comment Full text

Sesen Bio Inc (merger with a company Carisma Therapeutics Inc (NASDAQ:CARM)) (SESN)

  • Event
  • July 20, 2022, 12:00 UTC
  • 14
  • 1 comments

(99% Neutral) SESEN BIO, INC. (SESN) Announces Business Combination

Comment Full text

Abcam Plc (ABCM)

  • Event
  • July 20, 2022, 11:46 UTC
  • 11
  • 1 comments

(99% Neutral) Abcam Plc (ABCM) Files Form 6-K

Comment Full text

Biogen Inc (BIIB)

  • Event
  • July 20, 2022, 11:04 UTC
  • 14
  • 1 comments

(10% Negative) BIOGEN INC. (BIIB) Reports Q3 2022 Financial Results

Comment Full text

RPID

  • Event
  • July 20, 2022, 10:59 UTC
  • 93
  • 0 comments

New On-Demand Webinar Now Available

Comment Full text

Exelixis Inc (EXEL)

  • Event
  • July 19, 2022, 21:28 UTC
  • 14
  • 1 comments

(99% Neutral) EXELIXIS, INC. (EXEL) Announces Regulatory Update

Comment Full text

BioNTech SE (BNTX)

  • Event
  • July 19, 2022, 21:12 UTC
  • 11
  • 1 comments

(85% Positive) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K)

Comment Full text

Aquestive Therapeutics Inc (AQST)

  • Event
  • July 19, 2022, 20:46 UTC
  • 14
  • 1 comments

(99% Neutral) Aquestive Therapeutics, Inc. (AQST) Announces New Board Appointment

Comment Full text

Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE)

  • Event
  • July 19, 2022, 20:06 UTC
  • 14
  • 1 comments

(99% Neutral) AEGLEA BIOTHERAPEUTICS, INC. (AGLE) Files Form 8-K

Comment Full text

Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)

  • Event
  • July 19, 2022, 20:03 UTC
  • 11
  • 1 comments

(99% Neutral) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K

Comment Full text
  • Previous
  • 156
  • 157
  • 158
  • 159
  • 160
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2262)
  • SEC News(189438)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124590)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin